SCAPER expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.436400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.252200E-01
Normal-vs-Stage2
2.702000E-01
Normal-vs-Stage3
8.070400E-02
Normal-vs-Stage4
8.792000E-01
Stage1-vs-Stage2
8.363900E-02
Stage1-vs-Stage3
1.225790E-01
Stage1-vs-Stage4
9.536000E-01
Stage2-vs-Stage3
2.371600E-01
Stage2-vs-Stage4
1.219040E-01
Stage3-vs-Stage4
9.537700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.602200E-01
Normal-vs-AfricanAmerican
8.261200E-01
Normal-vs-Asian
3.336000E-01
Caucasian-vs-AfricanAmerican
5.855800E-01
Caucasian-vs-Asian
3.901400E-01
AfricanAmerican-vs-Asian
2.862400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.378800E-01
Normal-vs-Female
6.657200E-01
Male-vs-Female
3.902400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.442800E-01
Normal-vs-Age(41-60Yrs)
7.916000E-01
Normal-vs-Age(61-80Yrs)
4.820800E-01
Normal-vs-Age(81-100Yrs)
3.282000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.397000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.506430E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.735820E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.409800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.550200E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.876200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.302600E-01
Normal-vs-Daily Drinker
1.182630E-01
Normal-vs-Weekly Drinker
1.831600E-01
Normal-vs-Occasional Drinker
9.733000E-01
Normal-vs-Social Drinker
6.760800E-01
Non Drinker-vs-Daily Drinker
7.125600E-01
Non Drinker-vs-Weekly Drinker
8.113800E-01
Non Drinker-vs-Occasional Drinker
2.052200E-01
Non Drinker-vs-Social Drinker
4.691400E-01
Daily Drinker-vs-Weekly Drinker
9.423800E-01
Daily Drinker-vs-Occasional Drinker
1.551170E-01
Daily Drinker-vs-Social Drinker
3.473200E-01
Weekly Drinker-vs-Occasional Drinker
1.785620E-01
Weekly Drinker-vs-Social Drinker
4.071600E-01
Occasional Drinker-vs-Social Drinker
5.352800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.977600E-01
Normal-vs-Grade 2
9.452200E-02
Normal-vs-Grade 3
7.491900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.788190E-01
Grade 1-vs-Grade 3
2.763800E-01
Grade 1-vs-Grade 4
2.977600E-01
Grade 2-vs-Grade 3
5.537800E-01
Grade 2-vs-Grade 4
9.452200E-02
Grade 3-vs-Grade 4
7.491900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.308200E-01
Normal-vs-NonDiabetic
5.628600E-01
Diabetic-vs-NonDiabetic
3.714400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.887600E-02
Normal-vs-NoPancreatitis
5.507600E-01
Pancreatitis-vs-NoPancreatitis
1.497840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.070400E-01
Normal-vs-N1
3.116800E-01
N0-vs-N1
3.155200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.092800E-01
Normal-vs-TP53-NonMutant
9.251600E-01
TP53-Mutant-vs-TP53-NonMutant
1.805620E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
